(S (NP (NNP Glycemic) (NN control)) (VP (VBZ is) (ADJP (JJ essential) (PP (IN for) (NP (JJ critical) (NN care))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (PRP it)) (VP (VBZ is) (NP (DT a) (JJ challenging) (NN task)) (SBAR (IN because) (S (NP (EX there)) (VP (VBZ has) (VP (VBN been) (NP (NP (DT no) (NN study)) (PP (IN on) (NP (NP (JJ personalized) (JJ optimal) (NNS strategies)) (PP (IN for) (NP (JJ glycemic) (NN control))))))))))) (. .))
(S (NP (DT This) (NN work)) (VP (VBZ aims) (S (VP (TO to) (VP (VB learn) (NP (NP (VBN personalized) (JJ optimal) (JJ glycemic) (NNS trajectories)) (PP (IN for) (NP (ADJP (RB severely) (JJ ill)) (JJ septic) (NNS patients)))) (PP (IN by) (S (VP (VBG learning) (NP (NP (JJ data-driven) (NNS policies)) (SBAR (S (VP (TO to) (VP (VB identify) (NP (JJ optimal) (VBN targeted) (NN blood) (NN glucose) (NNS levels)) (PP (IN as) (NP (NP (DT a) (NN reference)) (PP (IN for) (NP (NNS clinicians))))))))))))))))) (. .))
(S (NP (PRP We)) (VP (VP (VBD encoded) (NP (JJ patient) (NNS states)) (S (VP (VBG using) (NP (DT a) (JJ sparse) (NN autoencoder))))) (CC and) (VP (VBD adopted) (NP (NP (DT a) (NN reinforcement) (VBG learning) (JJ paradigm)) (VP (VBG using) (NP (NN policy) (NN iteration)) (S (VP (TO to) (VP (VB learn) (NP (DT the) (JJ optimal) (NN policy)) (PP (IN from) (NP (NNS data)))))))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VBD estimated) (NP (NP (DT the) (JJ expected) (NN return)) (PP (VBG following) (NP (NP (DT the) (NN policy)) (VP (VBN learned) (PP (IN from) (NP (NP (DT the) (VBN recorded) (JJ glycemic) (NNS trajectories)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD yielded) (NP (NP (DT a) (NN function)) (VP (VBG indicating) (NP (NP (DT the) (NN relationship)) (PP (IN between) (NP (NP (JJ real) (NN blood) (NN glucose) (NNS values)) (CC and) (NP (JJ 90-day) (NN mortality) (NNS rates))))))))))))))))) (. .))
(S (NP (DT This)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (DT the) (JJ learned) (JJ optimal) (NN policy)) (VP (MD could) (VP (VB reduce) (NP (NP (DT the) (NNS patients) (POS â€º)) (VBN estimated) (CD 90-day) (NN mortality) (NN rate)) (PP (IN by) (NP (CD 6.3) (NN %))) (, ,) (PP (PP (IN from) (NP (CD 31) (NN %))) (PP (TO to) (NP (CD 24.7) (NN %))))))))) (. .))
(S (NP (DT The) (NN result)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP (NP (NN reinforcement) (VBG learning)) (PP (IN with) (NP (JJ appropriate) (NN patient) (NN state) (NN encoding)))) (VP (MD can) (ADVP (RB potentially)) (VP (VP (VB provide) (NP (JJ optimal) (JJ glycemic) (NNS trajectories))) (CC and) (VP (VB allow) (S (NP (NNS clinicians)) (VP (TO to) (VP (VB design) (NP (NP (DT a) (JJ personalized) (NN strategy)) (PP (IN for) (NP (NP (JJ glycemic) (NN control)) (PP (IN in) (NP (JJ septic) (NNS patients))))))))))))))) (. .))
